Efficacy of Adding Interleukin-2 to an Optimized Antiretroviral Regimen in HIV Patients in Therapeutic Failure (ANRS123)

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details. Identifier: NCT00113282
Recruitment Status : Completed
First Posted : June 8, 2005
Last Update Posted : December 22, 2011
Chiron Corporation
Information provided by (Responsible Party):
French National Agency for Research on AIDS and Viral Hepatitis

No Study Results Posted on for this Study
  Recruitment Status : Completed
  Actual Primary Completion Date : December 2007
  Actual Study Completion Date : February 2008